找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Liver Disease in Clinical Practice; Tim Cross Book 2022Latest edition Springer Nature Switzerland AG 2022 Hepatology.General Practice.Hepa

[復(fù)制鏈接]
樓主: vitamin-D
31#
發(fā)表于 2025-3-26 23:31:21 | 只看該作者
Chronic Hepatitis C,f left untreated, it progresses to liver fibrosis, cirrhosis, decompensated liver disease and hepatocellular carcinoma. The advent of directly acting antiviral therapies for CHC have revolutionised the treatment landscape. The vast majority of individuals can now be cured of chronic infection, inclu
32#
發(fā)表于 2025-3-27 02:12:06 | 只看該作者
Autoimmune Hepatitis and Overlap Syndromes, sexes. In the majority of cases, treatment with immunosuppressants is effective and has been shown to prolong survival, particularly when patients are diagnosed promptly and managed carefully. Although practical diagnostic criteria exist, diagnosis of AIH often remains a challenge given the heterog
33#
發(fā)表于 2025-3-27 05:34:56 | 只看該作者
IgG4-Related Hepato-Pancreato-Biliary Disease,ate with abundant IgG4-positive plasma cells and storiform pattern of fibrosis in affected organs. It usually presents insidiously with mass-like lesions and/or fibrotic plaques/strictures. Given its systemic manifestations, patients will present to a range of different generalists and sub-specialis
34#
發(fā)表于 2025-3-27 12:24:37 | 只看該作者
Hereditary Haemochromatosis,hereditary haemochromatosis (HH). The original description of the condition ‘bronze diabetes’ is now rare with earlier presentations being the norm due to increased awareness and easier diagnosis. Importantly, a diagnosis of HH can be made quite readily now in primary care via . genotyping. Liver bi
35#
發(fā)表于 2025-3-27 17:24:30 | 只看該作者
36#
發(fā)表于 2025-3-27 21:35:48 | 只看該作者
37#
發(fā)表于 2025-3-28 00:59:34 | 只看該作者
38#
發(fā)表于 2025-3-28 05:55:58 | 只看該作者
39#
發(fā)表于 2025-3-28 10:14:19 | 只看該作者
Liver Transplantation,ents with both acute and chronic liver diseases. Improvements and innovations in surgical technique, graft preservation and patient selection have led to increase in indications for LT, including some conditions that only a few years ago would have been considered absolute contraindications. The pro
40#
發(fā)表于 2025-3-28 11:40:59 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 03:40
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
台东市| 隆尧县| 棋牌| 南漳县| 湟中县| 黄浦区| 辽宁省| 乡宁县| 怀柔区| 温泉县| 元江| 宁阳县| 潜山县| 岳西县| 平安县| 扶沟县| 东明县| 准格尔旗| 平定县| 石柱| 册亨县| 天峻县| 陆川县| 法库县| 兴业县| 徐水县| 宜宾县| 灌云县| 大姚县| 赤峰市| 胶南市| 白水县| 永春县| 贵定县| 台安县| 通榆县| 文登市| 定远县| 诸暨市| 铅山县| 信阳市|